The article discusses how hyperspectral imaging (HSI) can detect retinal manifestations of neurodegenerative diseases like Alzheimer’s disease (AD) and age-related macular degeneration (AMD). The authors highlight that the retina, as an extension of the brain, can be noninvasively imaged to identify disease biomarkers. HSI offers a label-free method to detect these biomarkers, making it valuable for large-scale screening. The review also addresses current challenges and technological advancements needed to translate this approach into clinical practice.

To read the full article, click here: Hyperspectral retinal imaging in Alzheimer’s disease and age-related macular degeneration: a review